Neurofibromatosis laríngea pediátrica: reporte de localización atípica / Pediatric neurofibromatosis of the larynx: report of atypical location

Los neurofibromas laríngeos (NFL) son tumores benignos poco frecuentes de localización principalmente supraglótica. Se manifiestan con síntomas obstructivos de la vía aérea. El tratamiento es la resección completa del tumor mediante abordaje endoscópico; se reserva la cirugía abierta para tumores de gran extensión. Se presenta el caso de un paciente pediátrico con localización atípica de NFL asociado a neurofibromatosis tipo 1 (NF1). Se realizó resección endoscópica del tumor y la anatomía patológica informó neurofibroma plexiforme. Es importante sospechar de esta patología en todo niño con estridor inspiratorio atípico progresivo. Se sugiere seguimiento a largo plazo por la alta probabilidad de recidiva.

Laryngeal neurofibromas (LNFs) are rare benign tumors mainly located in the supraglottis. LNFs occur with airway obstruction symptoms. The treatment is complete resection via an endoscopic technique; the open approach is reserved for large tumors. Here we describe the case of a pediatric patient with LNF of atypical location associated with neurofibromatosis type 1 (NF-1). The tumor was resected with an endoscopic technique, and the pathological study reported a plexiform neurofibroma. It is important to suspect this condition in any child with atypical, progressive inspiratory stridor. Long-term follow-up is recommended due to the high rate of recurrence

Multiple strategies to avoid life-threatening blood loss during intralesional resection of a giant Plexiform Neurofibroma: A case report

@#Giant plexiform neurofibroma (PNs) are benign peripheral nerve sheath tumors known to contain multiple fascicles of nerve and numerous friable vascular components. Most consult due to significant disfigurement and functional deficit. Though surgery is the current standard of therapy, there is high reservation in pushing through with resection in most cases. The reservation stems from the recognized difficulty in controlling intraoperative life-threatening hemorrhage. A 25-year-old female came in our institution due to multiple debilitating giant PNs on her scalp, back, neck, shoulder, and chest. She opted for debulking surgery despite possible complications and recurrence. Multiple modalities used to prevent massive bleeding in this case included preoperative arterial embolization, energy sealing device, cutting linear stapler, and interlocking retention sutures. The aim of this case report was to discuss the utility of each of these techniques, the advantages and disadvantages of each approach based on our experience.

Neurofibroma plexiforme gigante del nervio ciático en una adulta burkinesa / Giant plexiform neurofibroma of the sciatic nerve in a Burkinabé adult

Se presenta el caso de una paciente de 36 años de edad con antecedente patológico de enfermedad de Von Reklinghausen, quien fue asistida en el Servicio de Cirugía General del Centro Hospitalario de Kossodô en Burkina Faso por presentar un tumor gigante en la región posterior del muslo derecho. Los exámenes complementarios confirmaron el presunto diagnóstico de neurofibroma plexiforme gigante del nervio ciático. Durante el procedimiento quirúrgico se extirpó un tumor infrecuente cuyo peso excedió los 22,5 kg. Con el tratamiento rehabilitador posoperatorio del miembro operado la paciente evolucionó satisfactoriamente y se le dio el alta hospitalaria 7 días después.

The case report of a 36 years patient with pathological history of Von Reklinghausen disease is presented. She was assisted in the General Surgery Service of the Hospital Center from Kossodô in Burkina Faso presenting a giant tumor in the back region of the right thigh. The complementary exams confirmed the presumed diagnosis of giant plexiform neurofibroma of the sciatic nerve. During the surgical procedure an uncommon tumor was removed which weight exceeded the 22.5 kg. With the postoperative rehabilitative treatment of the operated member the patient had a favorable clinical course and she was discharged from the hospital 7 days later.

Neurofibromatosis orbitotemporal gigante / Giant orbitotemporal neurofibromatosis / Neurofibromatose órbitotemporal gigante

La neurofibromatosis orbitotemporal es una enfermedad progresiva que comienza en la infancia y puede generar importantes alteraciones morfológicas y funcionales. Presentamos el caso de un paciente adulto con diagnóstico de neurofibromatosis orbitotemporal gigante, en el cual se realizó un tratamiento mediante embolización preoperatoria y resección quirúrgica con el fin de disminuir el tamaño tumoral.

Orbitotemporal neurofibromatosis is a progressive disease that begins in childhood and may cause important morphological and functional alterations. We present the case of an adult patient with a giant orbitotemporal neurofibromatosis, which was treated by preoperative embolization and a surgical resection to reduce the size of the tumor size.

A neurofibromatose órbito-temporal é uma enfermidade progressiva que começa na infância e pode gerar importantes alterações morfológicas e funcionais. Apresentamos o caso de um paciente adulto com diagnóstico de neurofibromatose órbito-temporal gigante, que foi submetido a tratamento com embolização pré-operatória e ressecção cirúrgica para diminuir o tamanho tumoral.

Neurofibroma Plexiforme Vesical em portador de Neurofibromatose: relato de caso / Bladder Plexiform Neurofibroma in Neurofibromatosis carrier: a case report / Neurofibroma Plexiforme Vesical en portador de Neurofibromatosis: relato de caso

Introdução: A neurofibromatose do tipo 1 (NF1) é uma doença hereditária de caráter autossômico dominante, com penetrância completa e relacionada a mutações no gene NF1 (17q11.2). Apresenta expressão extremamente variável e predisposição à ocorrência de tumores. Complicações como neurofibromas viscerais estão presentes em apenas 1% dos casos de NF1. Neurofibromas vesicais são extremamente raros. Relato do caso: O presente caso faz referência a um paciente do sexo masculino com 4 anos de idade que apresentava sinais e sintomas de disfunção urinária e intestinal associados a desvio da coluna lombossacra. Ao exame, foram identificadas características típicas de NF1 e os exames complementares permitiram o diagnóstico de um neurofibroma vesical. Posteriormente, foi concluído o diagnóstico de NF1. Conclusão: O diagnóstico de síndromes predisponentes ao câncer e o rastreio de tumores associados a essas condições são essenciais aos portadores dessas doenças.

Introduction: Type 1 neurofibromatosis is an inherited autosomal dominant disease with complete penetrance and is related to mutations in the NF1 gene (17q11.2). It presents extremely variable expression and predisposition to the occurrence of tumors. Complications such as visceral neurofibromas occurs in only 1% of NF1 cases. Vesical neurofibromas are extremely rare. Case report: Here in, we expose a case of a 4 years old boy, who presented signs and symptoms of urinary and intestinal dysfunction associated with lumbosacral spine deviation. His physical exam had neurofibromatosis type 1 features and the complementary exams revealed a vesical neurofibroma. Subsequently, a neurofibromatosis type 1 diagnosis was performed. Conclusion: Diagnose tumor predisposing syndromes and associated complications is essential for these patients.

Introducción: La neurofibromatosis tipo 1 es una enfermedad hereditaria de carácter autosómico dominante, con penetración completa y relacionada con mutaciones en el gen NF1 (17q11.2). Se presenta una expresión extremadamente variable y predisposición a la ocurrencia de tumores. Las complicaciones como los neurofibromas viscerales están presentes en sólo el 1% de los casos de NF1. Los neurofibromas vesicales son extremadamente raros. Relato del caso: Exponemos el caso de un niño de 4 años que presentaba signos y síntomas de disfunción urinaria e intestinal asociados a la desviación de la columna lumbosacra. En el examen se identificaron características típicas de neurofibromatosis y los exámenes complementarios permitieron el diagnóstico de un neurofibroma vesical. Se ha concluido el diagnóstico de neurofibromatosis del tipo 1. Conclusión: Diagnosticar los síndromes predisponentes del tumor y las complicaciones asociadas son esenciais para estos pacientes.

Neurofibroma plexiforme gigante: tratamento cirúrgico / Neurofibroma plexiforme Giant: surgical treatment

Contexto: Neurofibromatose (NF) é desordem neuroectodérmica; apresenta manifestações na pele, sistema nervoso, olhos e ossos. A variante tipo 1 (NF-1) é a mais frequente na população, tendo como critério diagnóstico a presença de pelo menos dois dos seguintes achados: seis ou mais manchas "café com leite" maiores que 0,5 cm em pré-púberes ou maiores que 1,5 cm após a puberdade; efélides axilares ou inguinais; dois ou mais neurofibromas ou um neurofibroma plexiforme; dois ou mais nódulos de Lisch; glioma óptico; displasia óssea e um parente de primeiro grau com NF-1. Descrição do caso: Paciente com 24 anos de idade, sexo masculino, apresentava efélides axilares; múltiplas máculas "café com leite" maiores que 1,5 cm distribuídas no tronco, dorso e membros inferiores; tumoração amolecida na região lombo-sacra à esquerda, compatível com neurofibroma plexiforme. Hipótese diagnóstica: neurofibromatose tipo 1 (NF-1). Realizada excisão do neurofibroma, o exame histopatológico não evidenciou transformação maligna. Discussão: NF-1 tem elevada prevalência na população (um caso em cada 3.000 habitantes). Neurofibromas plexiformes (NP) são neurofibromas que se estendem ao longo do trajeto de um nervo. Podem sofrer degeneração maligna a tumores da bainha do nervo periférico, sendo esta a principal causa de morte. Conclusão: A NF, especialmente a tipo 1, apresenta a possibilidade de acometimento multissistêmico, sendo fundamental o seguimento do paciente por equipe multiprofissional. Apresentamos um caso com tratamento por meio de excisão cirúrgica, a qual trouxe grande alívio ao paciente devido às dimensões e localização do neurofibroma plexiforme.

[ neurofibromatosis type 1 family report with multiple cases in 3 consecutive Generations]

Neurofibromatosis type1 [NF1] with the incidence of 1 in 3500 births, is the most common disorder which affects skin and peripheral nervous system. NF1 results from mutations in NF1 gene. The NF1 gene spans 350kbp and to date, nearly 2434 mutations in it were reported. The gene with 100 percent penetrance is located on chromosome 17 encoding neurofibromin protein. Recently, many challenges of its genetic analysis have been overcome through the application of new sequencing techniques. In present study patients with neurofibromatosis type 1 have been characterized from clinical symptoms such as presence of cafe au lait spot, plexiform neurofibroma, optic nerves involvement, presence of several patients in first degree relatives. These patients were in different ages including 73, 63, 44, 20 with different symptoms and severities of disease. In this communication, a NF1 family with 4 cases in 3 generations has been presented

Minimal change nephrotic syndrome showing complete remission after resection of a neurofibroma in a type I neurofibromatosis patient

No abstract available.

Solitary Pigmented Plexiform Neurofibroma in Lower Eyelid: A Case Report

PURPOSE: Solitary plexiform neurofibroma of the eyelid without neurofibromatosis is a rare disease. We report a case of solitary plexiform pigmented neurofibroma of the eyelid without neurofibromatosis. CASE SUMMARY: A 12-year-old male visited our clinic with a painless palpable subcutaneous mass on the right lower eyelid. He had a history of Batter syndrome and attention deficit hyperactivity disorder. On initial presentation, clinical features regarding neurofibromatosis such as Lisch nodule, optic nerve glioma, or high myopia were not observed. We performed excision and biopsy of the lower lid mass under general anesthesia. Macroscopically, the tumor was 4.0 × 1.5 × 1.5 cm in size with irregular nodules. Microscopically, the tumor consisted of multiple, variably sized tortous enlarged nerve fascicles with clusters of pigmented cells. Immunohistochemical results revealed expression of S-100 protein. Pigmented cells express both S-100 and melan-A proteins, while nonpigmented cells express S-100 protein only. The tumor was finally diagnosed as plexiform pigmented neurofibroma. Dermatological evaluation revealed no evidence of systemic neurofibromatosis. CONCLUSIONS: Plexiform neurofibroma should be considered in the differential diagnosis of an eyelid mass, even if the patient does not have a history or clinical features of neurofibromatosis. Plexiform neurofibroma can be successfully managed with surgical excision.

Isolated plexiform neurofibroma mimicking a vascular lesion

Abstract Plexiform neurofibromas are benign tumors originating from peripheral nerve sheaths, generally associated with Neurofibromatosis Type 1 (NF1). They are diffuse, painful and sometimes locally invasive, generating cosmetic problems. This report discusses an adolescent patient who presented with an isolated, giant plexiform neurofibroma on her leg that was confused with a vascular lesion due to its clinical aspects. Once the diagnosis was confirmed by surgical biopsy, excision of the lesion was performed with improvement of the symptoms.

A case of portal hypertension by presumed as plexiform neurofibroma at the hepatic hilum

Neurofibromas can occur anywhere in the body, but they usually involve the head, neck, pelvis, and extremities. Abdominal visceral involvement is rare, and intrahepatic involvement is even less common. We describe a patient who suffered from plexiform neurofibromatosis with liver involvement. A 49-year-old man, who had previously been diagnosed with neurofibromatosis, underwent esophagogastroduodenoscopy and abdominal ultrasonography for screening purposes. Esophagogastroduodenoscopy showed grade 2 esophageal varices and abdominal ultrasonography showed conglomerated nodules with echogenic appearances in the perihepatic space. Magnetic resonance imaging showed presumed plexiform neurofibroma involving the lesser sac and hepatic hilum and encasing the common hepatic artery celiac trunk and superior mesenteric artery left portal triad. We report an unusual case of portal hypertension attributed to the compressive narrowing of the portal vein by presumed as plexiform neurofibroma at the lesser sac and hepatic hilum.

Massive Plexiform Neurofibroma of the Neck and Larynx

Introduction Laryngeal neurofibromas are extremely rare, accounting for only 0.03 to 0.1% of benign tumors of the larynx. Objectives To report the first case of massive neck plexiform neurofibroma with intralaryngeal (supraglottic) extension in a 5-year-old boy with neurofibromatosis type 1 and to describe its treatment. Resumed Report This massive plexiform neurofibroma was surgically removed, relieving its significant respiratory obstructive symptoms without recurrence to date. Conclusion Massive neck plexiform neurofibroma with supraglottic part was found in a child with neurofibromatosis type 1; it should be included in differential diagnosis of stridor and neck mass in children. It was diagnosed and removed in early in childhood without recurrence.(AU)

Plexiform Neurofibroma: An Unusual Diagnosis of Lip Swellings.

Neurofibromas (NF) are seen either as a solitary lesion or as part of the generalized syndrome of NF (NF-1, also known as Von Recklinghausen disease of the skin). In plexiform neurofibroma (PN), there is proliferation of Schwann cells from the inner aspect of the nerve sheath, thereby resulting in an irregularly thickened, distorted, tortuous structure. Oral involvement by a solitary and peripheral PN in patients with no other signs of NF is rarely seen. It is reported that only 4-7% of patients affected by NF display oral manifestations. A solitary PN in a patient with no other symptoms is a diagnostic challenge, more so when the location of the lesion is one of the rarest sites.

Intraluminal Plexiform Unicystic Ameloblastoma: A Report of a Rarity in an 8-year-old Boy.

Unicystic ameloblastoma (UA) is a variant of ameloblastoma and this entity is more common in second to third decade of life. It is very rare in children with <2.2% under the age of 10 years. Th is odontogenic tumor is most commonly encountered in the posterior mandible and is associated with an impacted tooth. Th e term plexiform UA refers to a pattern of epithelial proliferation that has been described in cystic lesions of the jaws. Here is a report of a rare case of intraluminal plexiform UA, in the right posterior mandible of an 8-year-old boy presented to our department.

Preclinical Assessment of the Anticancer Drug Response of Plexiform Neurofibroma Tissue Using Primary Cultures

BACKGROUND AND PURPOSE: Individualized drug testing for tumors using a strategy analogous to antibiotic tests for infectious diseases would be highly desirable for personalized and individualized cancer care. METHODS: Primary cultures containing tumor and nontumor stromal cells were utilized in a novel strategy to test drug responses with respect to both efficacy and specificity. The strategy tested in this pilot study was implemented using four primary cultures derived from plexiform neurofibromas. Responses to two cytotoxic drugs (nilotinib and imatinib) were measured by following dose-dependent changes in the proportions of tumor and nontumor cells, determined by staining them with cell-type-specific antibodies. The viability of the cultured cells and the cytotoxic effect of the drugs were also measured using proliferation and cytotoxicity assays. RESULTS: The total number of cells decreased after the drug treatment, in accordance with the observed reduction in proliferation and increased cytotoxic effect upon incubation with the two anticancer drugs. The proportions of Schwann cells and fibroblasts changed dose-dependently, although the patterns of change varied between the tumor samples (from different sources) and between the two drugs. The highly variable in vitro drug responses probably reflect the large variations in the responses of tumors to therapies between individual patients in vivo. CONCLUSIONS: These preliminary results suggest that the concept of assessing in vitro drug responses using primary cultures is feasible, but demands the extensive further development of an application for preclinical drug selection and drug discovery.

Neurofibroma plexiforme solitário determinando obstrução pilórica: relato de caso / Solitary plexiform neurofibroma determining pyloric obstruction: a case report

Solitary gastric plexiform neurofibroma (PN) is a very rare tumor that originates from the peripheral nerves. PN is a rare cause of pyloric obstruction. A 58 year-old man, reported epigastric discomfort, nausea, and vomiting for two months. Upper digestive endoscopy showed a moderate/accentuated pyloric stenosis. Computed tomography (CT) and echoendoscopy revealed a pyloric nodule. The patient underwent to distal gastrectomy. Macroscopically, a gray nodule measuring 1.1 × 1.0 × 1.0 cm was identified. Using microscopy, a benign tumor composed of enlarged tortuous nerve fascicles showing a neurofibromatous proliferation with mild atypia and myxoid matrix was found. The lesion showed positive immunoexpression for S100, Leu7, and epithelial membrane antigen (EMA), and was negative for CD117, DOG-1, desmin, and smooth muscle actin. The diagnosis of PN was then determined...

Neurofibroma plexiforme (NP) gástrico solitário é um tumor muito raro originado a partir dos nervos periféricos. É uma causa rara de obstrução pilórica. Paciente masculino, 58 anos, relatava desconforto epigástrico, náuseas e vômitos durante dois meses. A endoscopia digestiva superior mostrou estenose moderada/acentuada do piloro. Tomografia computadorizada (TC)/ ecoendoscopia revelaram nódulo no piloro. O paciente foi submetido a gastrectomia distal. À macroscopia, identificou-se nódulo cinzento medindo 1.1 × 1 × 1 cm. À microscopia, encontrou-se tumor benigno composto por fascículos nervosos dilatados/ tortuosos, exibindo proliferação neurofibromatosa com atipias leves e matriz mixoide. A lesão exibiu imunoexpressão positiva para S100, Leu7 e antígeno da membrana epitelial (EMA), e negatividade para CD117, DOG-1, desmina e actina de músculo liso. O diagnóstico de PN foi, então, determinado...

Neurossarcoma plexiforme secundário à neurofibromatose tipo 1:relato de caso / Plexiform neurosarcoma secondary to Neurofibromatosis type 1: case report

A neurofibromatose tipo 1 é um transtorno neurocutâneo congênito caracterizado pela proliferação de tumores benignos da bainha dos nervos periféricos acompanhada de expressão inconstante a nível cutâneo, ósseo e nervoso. A evolução da doença é variável e dependente de possíveis complicações, sendo o prognóstico, em sua ausência, favorável. Os neurofibromas plexiformes são relativamente frequentes, constituindo complicação potencialmente grave, dependendo de sua localização e invasão de estruturas vizinhas. A transformação maligna desses tumores é rara, afetando 3 a 5% dos pacientes. O objetivo do estudo foi apresentar caso grave de neurofibromatose 1 com resultado fatal para o paciente, chamando a atenção para o diagnóstico das possíveis complicações. Paciente do gênero masculino, 20 anos, internado por massa cervical de etiologia a esclarecer. Com antecedentes de displasia tibial e duas exéreses de massas cutâneas não especificadas. Ao exame objetivo, apresentava múltiplas manchas café com leite, efélides axilares e inguinais, e nódulos na íris bilateralmente. Estabeleceu-se o diagnóstico de neurofibromatose1 em paciente sem história familiar, mediante dois resultados histopatológicos compatíveis. O estudo da massa revelou neurofibroma plexiforme cervicotorácico com malignização neurossarcomatosa, invadindo a veia jugular interna direita, artéria subclávia e plexo braquial, condicionando complicações hemorrágicas, posteriormente fatais. Apesar dos neurofibromas serem tumores benignos, estima-se que a esperança de vida dos pacientes com neurofibromatose 1 seja 15 anos menor do que a da população geral. A existência de complicações potencialmente fatais tornam indispensáveis a monitorização constante e o seguimento evolutivo das manifestações dessa doença

Neurofibromatosis type 1 is a congenital neurocutaneous disorder characterized by proliferation of benign peripheral nerve sheath tumors together with inconstant, cutaneous, osseous and neurological expression. Disease progression is variable and depends on eventual complications, with prognosis being favorable when they are absent. Plexiform neurofibroma is a relatively frequent and potentially severe complication, depending on its localization and surrounding structures. Malignant transformation is rare, affecting 3 to 5% of patients. The objective of this study was to present a severe case of neurofibromatosis 1, with fatal result for the patient, addressing the diagnosis of possible complications. Male patient, 20 years old, admitted due to cervical bulk of unknown origin, with a history of tibial dysplasia and two excisions of other unspecified cutaneous bulks. The physical examination showed multiple cafe-au-lait spots, axillary and inguinal ephelides, and bilateral iris Lisch nodules. Diagnosis of neurofibromatosis 1 was established in a patient without a family history, according to two compatible histopatological results. The investigation of the bulk demonstrated a plexiform cervical-thoracic neurofibroma with invasion of right internal jugular vein, subclavian artery and brachial plexus, with neurosarcomatous malignization, causing fatal hemorrhagic complications. In spite of neurofibromas being benign tumors, individuals with neurofibromatosis 1are predicted to have a lifespan of approximately 15 years less than the general population. Existence of potentially fatal complications makes close surveillance and follow-up of clinical manifestations crucial.

Neurofibromatosis type 1: a single center's experience in Korea / 소아과

PURPOSE: Neurofibromatosis 1 (NF1) is an autosomal dominant condition caused by an NF1 gene mutation. NF1 is also a multisystem disorder that primarily affects the skin and nervous system. The goal of this study was to delineate the phenotypic characterization and assess the NF1 mutational spectrum in patients with NF1. METHODS: A total of 42 patients, 14 females and 28 males, were enrolled in this study. Clinical manifestations and results of the genetic study were retrospectively reviewed. RESULTS: Age of the patients at the time of NF1 diagnosis was 15.8+/-14.6 years (range, 1-62 years). Twelve patients (28.6%) had a family history of NF1. Among the 42 patients, Cafe-au-lait spots were shown in 42 (100%), neurofibroma in 31 (73.8%), freckling in 22 (52.4%), and Lisch nodules in seven (16.7%). The most common abnormal finding in the brain was hamartoma (20%). Mental retardation was observed in five patients (11.9%), seizures in one patient (2.4%), and plexiform neurofibromas (PNFs) in four patients (9.5%). One patient with PNFs died due to a malignant peripheral nerve sheath tumor in the chest cavity. Genetic analysis of seven patients identified six single base substitutions (three missense and three nonsense) and one small deletion. Among these mutations, five (71.4%) were novel (two missense mutations: p.Leu1773Pro, p.His1170Leu; two nonsense mutations: p.Arg2517*, p.Cys2371*; one small deletion: p.Leu1944Phefs*6). CONCLUSION: The clinical characteristics of 42 Korean patients with NF1 were extremely variable and the mutations of the NF1 gene were genetically heterogeneous with a high mutation-detection rate.